{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:50:23Z","timestamp":1760784623709,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["AI083146"],"award-info":[{"award-number":["AI083146"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bmcl.2019.03.022","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T11:18:02Z","timestamp":1553080682000},"page":"1413-1418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-2639","authenticated-orcid":false,"given":"Victor","family":"Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Czyzyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Valhondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.03.022_b0005","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3201\/eid1303.060394","article-title":"Cryptosporidium hominis infection of the human respiratory tract","volume":"13","author":"Mercado","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.bmcl.2019.03.022_b0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ijpara.2017.08.001","article-title":"Innate immune responses play a key role in controlling infection of the intestinal epithelium by Cryptosporidium","volume":"47","author":"Laurent","year":"2017","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.bmcl.2019.03.022_b0015","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1017\/S0031182014001085","article-title":"Cryptosporidium species in humans and animals: current understanding and research needs","volume":"141","author":"Ryan","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.bmcl.2019.03.022_b0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1473-3099(14)70772-8","article-title":"A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium","volume":"15","author":"Checkley","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmcl.2019.03.022_b0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2217\/fmb.09.128","article-title":"Human immune responses in cryptosporidiosis","volume":"5","author":"Borad","year":"2010","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bmcl.2019.03.022_b0030","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1096\/fasebj.4.6.2180768","article-title":"Bifunctional thymidylate synthase-dihydrofolate reductase in protozoa","volume":"4","author":"Ivanetich","year":"1990","journal-title":"FASEB J"},{"key":"10.1016\/j.bmcl.2019.03.022_b0035","doi-asserted-by":"crossref","first-page":"52980","DOI":"10.1074\/jbc.M310328200","article-title":"Phylogenetic classification of protozoa based on the structure of the linker domain in the bifunctional enzyme, dihydrofolate reductase-thymidylate synthase","volume":"278","author":"O'Neil","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.03.022_b0040","series-title":"Cryptosporidium: parasite and disease","first-page":"361","article-title":"Cryptosporidium Metabolism","author":"Zhu","year":"2014"},{"key":"10.1016\/j.bmcl.2019.03.022_b0045","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/S0140-6736(05)66420-3","article-title":"Malaria","volume":"365","author":"Greenwood","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.bmcl.2019.03.022_b0050","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2217\/17460913.1.1.113","article-title":"Folate metabolism as a source of molecular targets for antimalarials","volume":"1","author":"Yuthavong","year":"2006","journal-title":"Future Microbiology"},{"key":"10.1016\/j.bmcl.2019.03.022_b0055","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1016\/j.bmcl.2014.07.049","article-title":"Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductase","volume":"24","author":"Kumar","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.03.022_b0060","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bmcl.2008.11.054","article-title":"Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen","volume":"19","author":"Martucci","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.03.022_b0065","doi-asserted-by":"crossref","DOI":"10.1039\/C3MD00141E","article-title":"Exploring novel strategies for AIDS protozoal pathogens: alpha-helix mimetics targeting a key allosteric protein-protein interaction in C. hominis TS-DHFR","volume":"4","author":"Martucci","year":"2013","journal-title":"Medchemcomm"},{"key":"10.1016\/j.bmcl.2019.03.022_b0070","doi-asserted-by":"crossref","first-page":"18314","DOI":"10.1074\/jbc.M400009200","article-title":"Kinetic characterization of bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) from Cryptosporidium hominis: a paradigm shift for ts activity and channeling behavior","volume":"279","author":"Atreya","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2019.03.022_b0075","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1042\/BJ20081247","article-title":"Disruption of the crossover helix impairs dihydrofolate reductase activity in the bifunctional enzyme TS-DHFR from Cryptosporidium hominis","volume":"417","author":"Vargo","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.bmcl.2019.03.022_b0080","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/bioinformatics\/bti315","article-title":"Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites","volume":"21","author":"Laurie","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.bmcl.2019.03.022_b0085","unstructured":"SiteMap, version 3.1, Schrodinger, LLC, New York, NY, 2014."},{"key":"10.1016\/j.bmcl.2019.03.022_b0090","unstructured":"Schrodinger Suite 2014-2 Protein Preparation Wizard; Epik version 2.8, Schrodinger, LLC, New York, NY, 2014."},{"key":"10.1016\/j.bmcl.2019.03.022_b0095","unstructured":"LigPrep, version 3.0, Schrodinger, LLC, New York, NY, 2014."},{"key":"10.1016\/j.bmcl.2019.03.022_b0100","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1568026616666160719163839","article-title":"Targeting Non-Catalytic Cysteine Residues Through Structure-Guided Drug Discovery","volume":"17","author":"Hallenbeck","year":"2017","journal-title":"Curr Top Med Chem"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19301611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19301611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:30:14Z","timestamp":1760772614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19301611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0960894X19301611"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.03.022","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel allosteric covalent inhibitors of bifunctional Cryptosporidium hominis TS-DHFR from parasitic protozoa identified by virtual screening","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}